As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established…
Thank you for reading this post, don't forget to subscribe!
Source: MIT Technology Review
Automatically aggregated summary — full article and all rights belong to the original publisher.